Prevention of preterm delivery [5]

New England Journal of Medicine

Volumn 357, Issue 19, 2007, Pages 1979-1980

  Tsatsaris, Vassilis ^a   Azria, Elie ^a   Goffinet, François ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; HORMONE RECEPTOR BLOCKING AGENT; OXYTOCIN RECEPTOR; UTERUS SPASMOLYTIC AGENT; ARGIPRESTOCIN; DRUG DERIVATIVE; PYRROLE DERIVATIVE;

CHILD DEATH; DRUG EFFICACY; HUMAN; LETTER; PREMATURE LABOR; PRIORITY JOURNAL; TOCOLYSIS; UNSPECIFIED SIDE EFFECT; DRUG ANTAGONISM; EPIDEMIOLOGY; FETUS MORTALITY; NOTE; PREMATURITY; DISEASE ASSOCIATION; HIGH RISK PATIENT; MEDICAL RECORD REVIEW; MORBIDITY; OUTCOME ASSESSMENT; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RISK ASSESSMENT; VAGINA CANDIDIASIS; VAGINA FLORA; FEMALE; MICROBIOLOGY; PREGNANCY;

BIAS (EPIDEMIOLOGY); FETAL MORTALITY; HUMANS; PREMATURE BIRTH; RECEPTORS, OXYTOCIN; TOCOLYTIC AGENTS; VASOTOCIN; CANDIDIASIS, VULVOVAGINAL; FEMALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 35848937309     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072557     Document Type: Letter

References (5)

1. Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med 2007;357:477-87.
2. Giles W, Bisits A. The present and future of tocolysis. Best Pract Res Clin Obstet Gynaecol (in press).
3. Tsatsaris V, Carbonne B, Cabrol D. Atosiban for preterm labour. Drugs 2004;64:375-82.
4. Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001;108:133-42.
5. Shim JY, Park YW, Yoon BH, et al. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. BJOG 2006;113:1228-34.